Series A funding round for NILO Therapeutics raising $100M in October 2025
Series A funding round for NILO Therapeutics raising $100M in October 2025
| Investor | Firm Type | Partner |
|---|
The Column GroupLEAD | Venture Capital | — |
DCVC BioLEAD | Venture Capital | — |
Lux CapitalLEAD | Venture Capital | — |
| Private | — |
| Venture Capital | — |
| Venture Capital | — |
This company has completed 1 funding round. Current round is highlighted.
Total Raised
$100M
Top Valuation
-
NILO Therapeutics raised $100M in a Series A round.
The round was announced on 10/01/25.
The round was led by Lux Capital, The Column Group, DCVC Bio.